Michael J. McElhaugh insider trades

Open-market stock purchases and sales by Michael J. McElhaugh, Interim President & CEO at Arbutus Biopharma Corp, from SEC Form 4 filings since Mar 1, 2019.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • ABUS Arbutus Biopharma Corp: 6 sales, last Feb 14, 2025

Get free alerts when Michael J. McElhaugh files a new trade →